全球小鼠模型技术市场规模、份额、趋势和成长分析报告（2026-2034）

预计小鼠模型技术市场将从 2025 年的 28.5 亿美元成长到 2034 年的 56.5 亿美元，2026 年至 2034 年的复合年增长率为 7.91%。

由于製药和生物技术领域临床前研究活动的增加，全球小鼠模型技术市场正稳定扩张。对疾病特异性和人源化小鼠模型的需求不断增长，正在增强肿瘤学、免疫学和遗传疾病领域的研究能力。药物发现和转化研究投入的增加进一步加速了市场发展。学术研究机构和受託研究机构是这项持续需求的主要贡献者。

主要成长要素包括基因组编辑技术的进步，特别是基于CRISPR的基因编辑技术，这些技术实现了快速、精准的模型建构。临床前试验服务外包的增加以及对安全性数据更严格的监管要求也推动了相关技术的应用。免疫肿瘤学研究和个人化医疗方法的兴起进一步增加了对先进基因工程模型的需求。

展望未来，人源化小鼠平台的改进和整合数据分析服务的提供预计将对市场产生积极影响。儘管伦理考量和替代测试技术可能会影响成长趋势，但体内研究的重要性仍然不变。提案更快模型建构速度、专用品系和全面研究服务的公司有望巩固其市场地位。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球小鼠模型技术市场：依技术划分

• 市场分析、洞察与预测
• CRISPR基因敲除
• CRISPR基因敲入
• 随机插入
• 大规模、有针对性的插入
• ES细胞修饰（同源重组）
• 其他的

第五章：全球小鼠模型技术市场：依最终用户划分

• 市场分析、洞察与预测
• 製药公司
• 生技公司
• 学术研究设施
• 合约研究和製造组织

第六章 全球小鼠模型技术市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Biocytogen
  • Charles River Laboratories
  • Cyagen Biosciences
  • Gempharmatech
  • GenOway
  • Ingenious Targeting Laboratory
  • Merck KGaA
  • Ozgene Pty Ltd
  • Taconic Biosciences Inc
  • PolyGene AG
  • The Jackson Laboratory

The Mice Model Technologies Market size is expected to reach USD 5.65 Billion in 2034 from USD 2.85 Billion (2025) growing at a CAGR of 7.91% during 2026-2034.

The Global Mice Model Technologies Market is expanding steadily due to increasing preclinical research activities in pharmaceuticals and biotechnology. Rising demand for disease-specific and humanized mouse models has strengthened research capabilities in oncology, immunology, and genetic disorders. Growing investments in drug discovery and translational research are further accelerating market development. Academic research institutions and contract research organizations are key contributors to sustained demand.

Major growth drivers include advancements in genome-editing technologies, particularly CRISPR-based modifications, which enable rapid and precise model development. Increased outsourcing of preclinical testing services and stricter regulatory requirements for safety data are also fueling adoption. The rise of immuno-oncology research and personalized medicine approaches further increases demand for advanced and genetically engineered models.

Looking ahead, the market is expected to benefit from improved humanized mouse platforms and integrated data analytics services. Ethical considerations and alternative testing technologies may influence growth dynamics, but whole-organism research will remain critical. Companies offering faster model generation, specialized strains, and comprehensive research services are likely to strengthen their market position.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• CRISPR Knockout
• CRISPR Knockin
• Random Insertions
• Large, Targeted Insertions
• ES Cell Modification (Homologous Recombination)
• Others

By End-User

• Pharmaceutical Companies
• Biotechnology Companies
• Academic and Research Facilities
• Contract Research and Manufacturing Organizations

COMPANIES PROFILED

• Biocytogen, Charles River Laboratories, Cyagen Biosciences, Gempharmatech, genOway, ingenious targeting laboratory, Merck KGaA, Ozgene Pty Ltd, Taconic Biosciences Inc, PolyGene AG, The Jackson Laboratory
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MICE MODEL TECHNOLOGIES MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. CRISPR Knockout Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. CRISPR Knockin Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Random Insertions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Large, Targeted Insertions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. ES Cell Modification (Homologous Recombination) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MICE MODEL TECHNOLOGIES MARKET: BY END-USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-user
• 5.2. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Academic and Research Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Contract Research and Manufacturing Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MICE MODEL TECHNOLOGIES MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Technology
  • 6.2.2 By End-user
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Technology
  • 6.3.2 By End-user
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Technology
  • 6.4.2 By End-user
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Technology
  • 6.5.2 By End-user
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Technology
  • 6.6.2 By End-user
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL MICE MODEL TECHNOLOGIES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Biocytogen
  • 8.2.2 Charles River Laboratories
  • 8.2.3 Cyagen Biosciences
  • 8.2.4 Gempharmatech
  • 8.2.5 GenOway
  • 8.2.6 Ingenious Targeting Laboratory
  • 8.2.7 Merck KGaA
  • 8.2.8 Ozgene Pty Ltd
  • 8.2.9 Taconic Biosciences Inc
  • 8.2.10 PolyGene AG
  • 8.2.11 The Jackson Laboratory